LifeStance Health Group Inc
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
LFST$14.56-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
(In thousands, except for Net Loss per Share)
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| TOTAL REVENUE | $300,437 | $252,589 |
| OPERATING EXPENSES | ||
| Center costs, excluding depreciation and amortization shown separately below | 205,711 | 182,987 |
| General and administrative expenses | 88,934 | 84,626 |
| Depreciation and amortization | 22,564 | 19,069 |
| Total operating expenses | $317,209 | $286,682 |
| LOSS FROM OPERATIONS | $(16,772) | $(34,093) |
| OTHER EXPENSE | ||
| Gain on remeasurement of contingent consideration | 2,015 | 1,037 |
| Transaction costs | — | (86) |
| Interest expense, net | (5,903) | (5,092) |
| Other expense | (74) | (45) |
| Total other expense | $(3,962) | $(4,186) |
| LOSS BEFORE INCOME TAXES | (20,734) | (38,279) |
| INCOME TAX (PROVISION) BENEFIT | (363) | 4,037 |
| NET LOSS | $(21,097) | $(34,242) |
| NET LOSS PER SHARE, BASIC AND DILUTED | (0.06) | (0.09) |
| Weighted-average shares used to compute basic and diluted net loss per share | 376,331 | 360,902 |
| NET LOSS | $(21,097) | $(34,242) |
| OTHER COMPREHENSIVE INCOME (LOSS) | ||
| Unrealized gains (losses) on cash flow hedge, net of tax | 583 | (1,270) |
| COMPREHENSIVE LOSS | $(20,514) | $(35,512) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.